Showing results (291-300 of 898) with videos related to

Sort By:
Pageof 90
Frontiers in Allergy|October 29, 2025
Use of oral corticosteroids in patients with asthma: how far is clinical practice from the guidelines? Results from surveys of patients and doctorsLuisa Brussino, Gianna Camiciottoli, Annalisa Stassaldi, et al.
Frontiers in Allergy|October 20, 2025
Case Report: Not all recurrent "idiopathic" anaphylaxis is idiopathicSally Mahgoub Khalil, Sherin Rahim, Hassan Mobayed, et al.
Frontiers in Allergy|October 9, 2025
Correction: Real-life effectiveness of once-daily single-inhaler triple therapy (FF-UMEC-VI) after switching from dual therapy (ICS-LABA) in patients with symptomatic asthma: trelegy ellipta for real asthma control studyYoshitomo Kushima, Yasuo Shimizu, Ryo Arai, et al.
Frontiers in Allergy|October 16, 2025
The recent advances of mast cells in the pathogenesis of atopic dermatitisZhenzhen Xiao, Yunqian Zhuo, Rui Li, et al.
Frontiers in Allergy|October 1, 2025
Efficacy and safety of a 4-step versus a 5-step egg ladder in children with IgE-mediated hen's egg protein allergy: protocol for an open-label randomized controlled trialAndrea Horvath, Anna Bujnowska, Agata Stróżyk, et al.
Frontiers in Allergy|October 1, 2025
Correction: Gut microbiota-metabolome crosstalk in allergic diseases: mechanistic insights and translational opportunitiesHanBin Qin, Jiaxin Sui, Shuang Wang, et al.
Frontiers in Allergy|August 18, 2025
Advancing equity in allergy and immunology: progress, pitfalls, and the path forwardPhilip Mendez, Ayobami Akenroye, Sharmilee M Nyenhuis, et al.
Frontiers in Allergy|August 4, 2025
Contemporary office-based procedures in rhinology: a narrative review of techniques, indications, and outcomesGhassan Alokby
Frontiers in Allergy|September 8, 2025
Mugwort sensitization and asthma as predictors of food-induced anaphylactic shock in children: a retrospective study in Northern ChinaZibei Zhou, Juan Zhang, Nini Dai, et al.
Frontiers in Allergy|August 6, 2025
Shrimp oral immunotherapy outcomes in the phase 2 clinical trial: MOTIFShirley Y Jiang, Shu Cao, Kristine Martinez, et al.
Pageof 90